Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

CAR-T ICU 2019 | EuroCARTForce: a platform for progress

Michael von Bergwelt • 10 Jul 2019
CAR-T ICU 2019
CAR-T

In this video, Michael von Bergwelt, MD, LMU Hospital Munich, Munich, Germany, discusses the objectives of the formation of EuroCARTForce and the challenges of utilizing CAR T cells and immunotherapy. This interview took place at the CAR-T Cell Therapy and the ICU meeting in London, UK, which was organized by EuroCARTForce.

More from Michael von Bergwelt

Increase in cancer patient transfers to the ICU: what does it come down to?
2:25
Increase in cancer patient transfers to the ICU: what does it come down to?
Michael von Bergwelt • 10 Jul 2019
Preparing the critical care workforce for CAR-T
1:14
Preparing the critical care workforce for CAR-T
Michael von Bergwelt • 10 Jul 2019
Intensive care for CAR-T: bridge to treatment and response
2:30
Intensive care for CAR-T: bridge to treatment and response
Michael von Bergwelt • 15 Mar 2019
Learnings from a CAR-T center: leukapheresis, bridging therapy, toxicities & more
3:43
Learnings from a CAR-T center: leukapheresis, bridging therapy, toxicities & more
Michael von Bergwelt • 15 Mar 2019

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJHemOnc is intended for healthcare professionals